British Columbia Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-359,000
| Closed | -$34.1M | – | 791 |
|
|
2024
Q1 | $34.1M | Hold |
359,000
| – | – | 0.24% | 90 |
|
|
2023
Q4 | $32.1M | Buy |
359,000
+44,000
| +14% | +$3.93M | 0.26% | 79 |
|
|
2023
Q3 | $23M | Hold |
315,000
| – | – | 0.22% | 94 |
|
|
2023
Q2 | $26.2M | Buy |
315,000
+20,000
| +7% | +$1.66M | 0.24% | 85 |
|
|
2023
Q1 | $22.5M | Buy |
295,000
+115,000
| +64% | +$8.76M | 0.23% | 78 |
|
|
2022
Q4 | $14.9M | Buy |
180,000
+97,500
| +118% | +$8.09M | 0.16% | 110 |
|
|
2022
Q3 | $6.54M | Buy |
+82,500
| New | +$6.54M | 0.07% | 228 |
|